Verily partners with Duke, Stanford to launch massive “ baseline ” health study

Verily Life Sciences, the medical arm of Google parent Alphabet (NSDQ:GOOGL), said today it is launching a 4-year, 10,000-patient study looking to examine how people transition from healthy to sick and to identify additional disease risk factors. The company will partner with Duke University and Stanford Medicine, with enrollments beginning in the coming months. Study participants will also be enrolled at the California Health and Longevity Institute in Westlake Village, Calif. The study will be the 1st initiative of its “Project Baseline,” which looks to establish a baseline definition for health and what it means. “Through the Project Baseline study, we are aiming to engineer a true twenty-first century approach to health – in a preventive and personalized way. Instead of having the annual physical exam that has not changed in decades, we’re hoping to develop new platforms that will discover changes in health as they happen in meaningful and actionable ways. To do this successfully, we will partner with participants to learn and deliver the best approaches for every aspect of the study,” Dr. Adrian Hernandez of the Duke Clinical Research Institute said in a prepared statement. Data will be gathered through the collection of biological samples alongside data collected from clinical visits and from its Study Watch wearable heart rate and activity tracker. Eventually, Verily said that de-identified data from Project Baseline will be availab...
Source: Mass Device - Category: Medical Equipment Authors: Tags: Clinical Trials Patient Monitoring Verily Source Type: news